Perry Hooper, MD
MOHS-Micrographic Surgery · Carmel, INNPI 1083119804
Payments from drug & device makers
What this record shows
22 manufacturers reported payments, led by Integra Lifesciences Corporation at 51.8% of the total. 2025 is the largest year on record at $2,813, 4.2 times the $674 reported in 2022.
Across 123 payments — averaging $38.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$2K
- AbbVie$423
- E.r. Squibb & Sons, L.L.C.$276
- Incyte Corporation$259
- Regeneron Healthcare Solutions, Inc.$174
- Amgen$136
- plus $1K from 16 others
What the payments were for
- Food & beverage$2,31849%
- Other$2,44351%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 12 | $2,465 |
| AbbVie(2 entities) | 15 | $423 |
| E.r. Squibb & Sons, L.L.C. | 9 | $276 |
| Incyte Corporation | 8 | $259 |
| Regeneron Healthcare Solutions, Inc. | 7 | $174 |
| Amgen | 5 | $136 |
| Lilly USA, LLC | 6 | $127 |
| Mayne Pharma Commercial LLC | 28 | $108 |
| Sun Pharmaceutical Industries Inc. | 5 | $104 |
| LEO Pharma Inc. | 4 | $87 |
| Johnson & Johnson | 3 | $71 |
| Smith+Nephew | 2 | $65 |
| Novartis | 2 | $63 |
| UCB, Inc. | 3 | $63 |
| Sanofi | 2 | $56 |
| Boehringer Ingelheim | 2 | $55 |
| Convatec Inc. | 2 | $54 |
| Pfizer | 2 | $51 |
| Kerecis Limited | 2 | $39 |
| Galderma Laboratories, L.p. | 2 | $38 |
| Organogenesis Inc. | 1 | $29 |
| Sweetbio, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMNIOEXCEL$1,802
- CYTAL$369
- Sotyktu$114
- Rinvoq$108
How this compares
Too few mohs-micrographic surgery providers in Indianato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 383 | $2,938 |
| Mupirocin | 369 | $2,507 |
| Cephalexin | 68 | $424 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $105 |
| Amoxicillin | 69 | $54 |
| Diclofenac Sodium | 12 | $21 |
| Tramadol Hcl | 24 | $19 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Carmel
- Carl HankeIndianapolis$96K
- Rachel WardMuncie$9K
- Eduardo RiveraMadison$8K
- John RandallWest Lafayette$6K
- David SurprenantEvansville$5K
- Brian WilliamsGreenwood$5K
- Shayna GordonPlainfield$4K
- Jane LimEvansville$4K
- Thomas McGovernFort Wayne$4K
- Sreya TalasilaPortage$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.